Military service members and veterans face serious occupational trauma; one element in particular relates to the significantly increased risk of acute and chronic neuropsychiatric conditions.
Neuropsychiatric conditions in the military are particularly impactful because options for treating them
No therapy currently exists that can deliver rapid relief of neuropsychiatric symptoms and is reasonable for use in a broad spectrum of conditions.
Neuropsychiatric conditions are complex, and presentation is highly subject to significant inter-individual variability.
Focused Pharma aims to develop new drugs that target specific neurotransmitter receptor signaling modes to deliver near immediate relief that is generalizable across indications and individuals.